O
Ole Wichmann
Researcher at Robert Koch Institute
Publications - 228
Citations - 7533
Ole Wichmann is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 43, co-authored 200 publications receiving 6223 citations. Previous affiliations of Ole Wichmann include Ludwig Maximilian University of Munich & Humboldt University of Berlin.
Papers
More filters
Beschluss und Wissenschaftliche Begründung der Ständigen Impfkommission (STIKO) für die Aktualisierung der Influenza-Impfempfehlung für Personen im Alter von ≥ 60 Jahren
Kai Michaelis,Stefan Scholz,Silke Buda,Edeltraut Garbe,Thomas Harder,Thomas Ledig,Martin Terhardt,Ole Wichmann,Sabine Wicker,Fred Zepp,Thomas Mertens +10 more
Journal ArticleDOI
High residual chloroquine blood levels in African children with severe malaria seeking healthcare
Ole Wichmann,Teunis A. Eggelte,Sabine Gellert,Maha E. Osman,Franziska Mylius,Stephan Ehrhardt,Sylvester D. Anemana,Ulrich Bienzle,Frank P. Mockenhaupt +8 more
TL;DR: Residual chloroquine concentrations were found to be abundant in children with severe malaria and to be associated with alterations in the clinical manifestation of the disease and its case fatality, which may result from toxic effects of the drug and/or reflect preceding overtreatment inChildren with acute life-threatening disease.
Welche Impfquote ist notwendig, um COVID-19 zu kontrollieren?
Ole Wichmann,Stefan Scholz,Maria Waize,Nora Schmid-Küpke,Osamah Hamouda,Lothar Wieler,Lars Schaade +6 more
Journal ArticleDOI
Use of existing systematic reviews for evidence assessments in infectious disease prevention: a comparative case study
TL;DR: The five-step approach provided useful and structured guidance and should be routinely applied when using existing SRs as a basis for evidence-based recommendations in public health.
Journal ArticleDOI
Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination.
TL;DR: In conclusion, pediatricians showed distinct preferences regarding possible integration of MenB vaccination into the existent immunization schedule and as physicians play a crucial role in the implementation, findings will be useful in decision-making regarding potential introduction.